JMP Securities Keeps Their Buy Rating on Blue Owl Capital (OBDC)
JMP Securities analyst Brian McKenna reiterated a Buy rating on Blue Owl Capital (OBDC – Research Report) today and set a price target of ...
JMP Securities Sticks to Their Buy Rating for Braze (BRZE)
JMP Securities analyst Patrick Walravens maintained a Buy rating on Braze (BRZE – Research Report) today and set a price target of $68.00. The ...
JMP Securities maintains AN2 Therapeutics stock with $5 target
JMP Securities reiterated its Market Outperform rating on AN2 Therapeutics (NASDAQ:ANTX) shares, maintaining a $5.00 price target, representing significant upside from the current price of $1.14.
JMP Securities maintains Roku stock with $95 target
JMP Securities reaffirmed its Market Outperform rating on Roku Inc. (NASDAQ:ROKU) with a steady price target of $95.00. According to InvestingPro data, Roku's stock has shown significant momentum with ...
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...
ETF Daily News4d
JMP Securities Reiterates Market Outperform Rating for Chubb (NYSE:CB)
Chubb (NYSE:CB – Get Free Report)‘s stock had its “market outperform” rating reiterated by JMP Securities in a research report issued on Wednesday,Benzinga reports. They currently have a $ ...
ETF Daily News4d
JMP Securities Reiterates “Market Outperform” Rating for Alexandria Real Estate Equities (NYSE:ARE)
JMP Securities’ price objective would indicate a potential upside of 35.66% from the stock’s current price. Several other equities research analysts have also issued reports on the stock.
Nasdaq6d
JMP Securities Initiates Coverage of Astria Therapeutics (ATXS) with Market Outperform Recommendation
Fintel reports that on January 31, 2025, JMP Securities initiated coverage of Astria Therapeutics (NasdaqGM:ATXS) with a Market Outperform recommendation. As of January 29, 2025, the average one ...
Cloudflare, CyberArk see price targets raised at JMP ahead of earnings
JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...
Nasdaq7d
JMP Securities Initiates Coverage of KalVista Pharmaceuticals (KALV) with Market Outperform Recommendation
Fintel reports that on January 31, 2025, JMP Securities initiated coverage of KalVista Pharmaceuticals (NasdaqGM:KALV) with a Market Outperform recommendation. As of January 28, 2025, the average ...
Meta's AI Investments, Llama Expansion, Ad Tech Growth Earn Analyst Conviction
Meta Platforms, Inc (NASDAQ:META) stock is trading higher after multiple firms raised their price forecasts on the stock ...
Investing3d
JMP Securities starts Astria Therapeutics stock at Market Outperform
On Friday, JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a price target of $26.00. The stock, currently trading at $7.49, ...